Dr Philip Joseph Martin, MD | |
2025 Glenn Mitchell Dr, Virginia Beach, VA 23456-0178 | |
(252) 636-5509 | |
(757) 363-6204 |
Full Name | Dr Philip Joseph Martin |
---|---|
Gender | Male |
Speciality | Anesthesiology |
Experience | 24 Years |
Location | 2025 Glenn Mitchell Dr, Virginia Beach, Virginia |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1609885557 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207L00000X | Anesthesiology | 0101257369 (Virginia) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Adventhealth Sebring | Sebring, FL | Hospital |
Bayfront Health - St Petersburg | Saint petersburg, FL | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Ams National Llc | 3870813025 | 203 |
Anesthesiologists Of Greater Orlando Inc | 7416928536 | 257 |
Sheridan Healthcorp Inc | 3173429693 | 866 |
News Archive
Atacama Labs Oy has developed an innovative oral drug delivery technology (called 'pneumatic dry granulation' or 'PDG Technology(TM)'). The technology is aimed to replace existing solid dosage form development and manufacturing methods (like wet granulation or standard roller compaction) and will help both NCE galenic developers and life cycle managers to overcome development or differentiation issues.
England footballers who have been suffering in the Portuguese heat could benefit from a new hi-tech football shirt that alerts managers to players heart rate and hydration levels.
Today, MedImmune announced that researchers will present data from its oncology portfolio, including new clinical data, at two upcoming medical congresses in Europe and the United States.
Researchers from the Jacks Laboratory at MIT's Koch Institute for Integrative Cancer Research (KI) have developed and characterized a genetically engineered mouse that successfully models progression from papillary thyroid cancer, which has an excellent prognosis, to anaplastic thyroid cancer (ATC), a highly lethal disease.
› Verified 9 days ago
Entity Name | Sheridan Healthcorp Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1629781711 PECOS PAC ID: 3173429693 Enrollment ID: O20031208000355 |
News Archive
Atacama Labs Oy has developed an innovative oral drug delivery technology (called 'pneumatic dry granulation' or 'PDG Technology(TM)'). The technology is aimed to replace existing solid dosage form development and manufacturing methods (like wet granulation or standard roller compaction) and will help both NCE galenic developers and life cycle managers to overcome development or differentiation issues.
England footballers who have been suffering in the Portuguese heat could benefit from a new hi-tech football shirt that alerts managers to players heart rate and hydration levels.
Today, MedImmune announced that researchers will present data from its oncology portfolio, including new clinical data, at two upcoming medical congresses in Europe and the United States.
Researchers from the Jacks Laboratory at MIT's Koch Institute for Integrative Cancer Research (KI) have developed and characterized a genetically engineered mouse that successfully models progression from papillary thyroid cancer, which has an excellent prognosis, to anaplastic thyroid cancer (ATC), a highly lethal disease.
› Verified 9 days ago
Entity Name | Anesthesiologists Of Greater Orlando Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1457300998 PECOS PAC ID: 7416928536 Enrollment ID: O20040803000929 |
News Archive
Atacama Labs Oy has developed an innovative oral drug delivery technology (called 'pneumatic dry granulation' or 'PDG Technology(TM)'). The technology is aimed to replace existing solid dosage form development and manufacturing methods (like wet granulation or standard roller compaction) and will help both NCE galenic developers and life cycle managers to overcome development or differentiation issues.
England footballers who have been suffering in the Portuguese heat could benefit from a new hi-tech football shirt that alerts managers to players heart rate and hydration levels.
Today, MedImmune announced that researchers will present data from its oncology portfolio, including new clinical data, at two upcoming medical congresses in Europe and the United States.
Researchers from the Jacks Laboratory at MIT's Koch Institute for Integrative Cancer Research (KI) have developed and characterized a genetically engineered mouse that successfully models progression from papillary thyroid cancer, which has an excellent prognosis, to anaplastic thyroid cancer (ATC), a highly lethal disease.
› Verified 9 days ago
Entity Name | Greater Florida Anesthesiologists Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1528630795 PECOS PAC ID: 3173711017 Enrollment ID: O20101220000829 |
News Archive
Atacama Labs Oy has developed an innovative oral drug delivery technology (called 'pneumatic dry granulation' or 'PDG Technology(TM)'). The technology is aimed to replace existing solid dosage form development and manufacturing methods (like wet granulation or standard roller compaction) and will help both NCE galenic developers and life cycle managers to overcome development or differentiation issues.
England footballers who have been suffering in the Portuguese heat could benefit from a new hi-tech football shirt that alerts managers to players heart rate and hydration levels.
Today, MedImmune announced that researchers will present data from its oncology portfolio, including new clinical data, at two upcoming medical congresses in Europe and the United States.
Researchers from the Jacks Laboratory at MIT's Koch Institute for Integrative Cancer Research (KI) have developed and characterized a genetically engineered mouse that successfully models progression from papillary thyroid cancer, which has an excellent prognosis, to anaplastic thyroid cancer (ATC), a highly lethal disease.
› Verified 9 days ago
Entity Name | Ams National Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1316330830 PECOS PAC ID: 3870813025 Enrollment ID: O20150529000613 |
News Archive
Atacama Labs Oy has developed an innovative oral drug delivery technology (called 'pneumatic dry granulation' or 'PDG Technology(TM)'). The technology is aimed to replace existing solid dosage form development and manufacturing methods (like wet granulation or standard roller compaction) and will help both NCE galenic developers and life cycle managers to overcome development or differentiation issues.
England footballers who have been suffering in the Portuguese heat could benefit from a new hi-tech football shirt that alerts managers to players heart rate and hydration levels.
Today, MedImmune announced that researchers will present data from its oncology portfolio, including new clinical data, at two upcoming medical congresses in Europe and the United States.
Researchers from the Jacks Laboratory at MIT's Koch Institute for Integrative Cancer Research (KI) have developed and characterized a genetically engineered mouse that successfully models progression from papillary thyroid cancer, which has an excellent prognosis, to anaplastic thyroid cancer (ATC), a highly lethal disease.
› Verified 9 days ago
Entity Name | American Anesthesiology Services Of Florida Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1508318387 PECOS PAC ID: 1850674540 Enrollment ID: O20170202001989 |
News Archive
Atacama Labs Oy has developed an innovative oral drug delivery technology (called 'pneumatic dry granulation' or 'PDG Technology(TM)'). The technology is aimed to replace existing solid dosage form development and manufacturing methods (like wet granulation or standard roller compaction) and will help both NCE galenic developers and life cycle managers to overcome development or differentiation issues.
England footballers who have been suffering in the Portuguese heat could benefit from a new hi-tech football shirt that alerts managers to players heart rate and hydration levels.
Today, MedImmune announced that researchers will present data from its oncology portfolio, including new clinical data, at two upcoming medical congresses in Europe and the United States.
Researchers from the Jacks Laboratory at MIT's Koch Institute for Integrative Cancer Research (KI) have developed and characterized a genetically engineered mouse that successfully models progression from papillary thyroid cancer, which has an excellent prognosis, to anaplastic thyroid cancer (ATC), a highly lethal disease.
› Verified 9 days ago
Entity Name | Capital Anesthesia Solutions Of Florida Ii, Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1891318481 PECOS PAC ID: 7911323720 Enrollment ID: O20200811002165 |
News Archive
Atacama Labs Oy has developed an innovative oral drug delivery technology (called 'pneumatic dry granulation' or 'PDG Technology(TM)'). The technology is aimed to replace existing solid dosage form development and manufacturing methods (like wet granulation or standard roller compaction) and will help both NCE galenic developers and life cycle managers to overcome development or differentiation issues.
England footballers who have been suffering in the Portuguese heat could benefit from a new hi-tech football shirt that alerts managers to players heart rate and hydration levels.
Today, MedImmune announced that researchers will present data from its oncology portfolio, including new clinical data, at two upcoming medical congresses in Europe and the United States.
Researchers from the Jacks Laboratory at MIT's Koch Institute for Integrative Cancer Research (KI) have developed and characterized a genetically engineered mouse that successfully models progression from papillary thyroid cancer, which has an excellent prognosis, to anaplastic thyroid cancer (ATC), a highly lethal disease.
› Verified 9 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Philip Joseph Martin, MD Po Box 79763, Baltimore, MD 21279-0763 Ph: (252) 636-5509 | Dr Philip Joseph Martin, MD 2025 Glenn Mitchell Dr, Virginia Beach, VA 23456-0178 Ph: (252) 636-5509 |
News Archive
Atacama Labs Oy has developed an innovative oral drug delivery technology (called 'pneumatic dry granulation' or 'PDG Technology(TM)'). The technology is aimed to replace existing solid dosage form development and manufacturing methods (like wet granulation or standard roller compaction) and will help both NCE galenic developers and life cycle managers to overcome development or differentiation issues.
England footballers who have been suffering in the Portuguese heat could benefit from a new hi-tech football shirt that alerts managers to players heart rate and hydration levels.
Today, MedImmune announced that researchers will present data from its oncology portfolio, including new clinical data, at two upcoming medical congresses in Europe and the United States.
Researchers from the Jacks Laboratory at MIT's Koch Institute for Integrative Cancer Research (KI) have developed and characterized a genetically engineered mouse that successfully models progression from papillary thyroid cancer, which has an excellent prognosis, to anaplastic thyroid cancer (ATC), a highly lethal disease.
› Verified 9 days ago
Gary Jay Waxman, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 816 Independence Blvd, Ste 2a, Virginia Beach, VA 23455 Phone: 757-363-6712 Fax: 757-363-6204 | |
Dr. Daphne Michelle Lenox, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 134 Business Park Dr, Virginia Beach, VA 23462 Phone: 757-473-0055 | |
Dr. Stephen Michael Bronaugh, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 134 Business Park Dr, Virginia Beach, VA 23462 Phone: 757-473-0044 | |
Francis T Verfurth, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1060 First Colonial Rd, Virginia Beach, VA 23454 Phone: 757-395-8369 | |
George N Vretakis, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 138 S Rosemont Rd, Ste 215, Virginia Beach, VA 23452 Phone: 757-431-9551 Fax: 757-431-9663 | |
Dr. Jennifer Nicole Georgi, Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 134 Business Park Dr, Virginia Beach, VA 23462 Phone: 757-473-0044 | |
Dr. Monford Wolf, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1975 Glenn Mitchell Dr, Suite 300, Virginia Beach, VA 23456 Phone: 757-507-0170 |